Rhinovirus-bacteria coexposure synergistically induces CCL20 production from human bronchial epithelial cells

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 312, Issue 5, 2017, Pages L731-L740

  Maciejewski, Barbara A ^a   Jamieson, Kyla C ^a   Arnason, Jason W ^a   Kooi, Cora ^a   Wiehler, Shahina ^a   Traves, Suzanne L ^a   Leigh, Richard ^a   Proud, David ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Antimicrobial immunity; Bacteria; Chemokines; Epithelial cells; Rhinovirus

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; BETA DEFENSIN 2; GENTAMICIN; INTERLEUKIN 17C; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; 6 CHLORO 8 NICOTINAMIDO BETA CARBOLINE; CCL20 PROTEIN, HUMAN; DACTINOMYCIN; FUSED HETEROCYCLIC RINGS; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROTEIN KINASE INHIBITOR; PYRIDINE DERIVATIVE; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; AIRWAY EPITHELIUM CELL; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; CELL STIMULATION; CLINICAL OUTCOME; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG POTENTIATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN RHINOVIRUS; HUMAN RHINOVIRUS A1; HUMAN RHINOVIRUS A16; INNATE IMMUNITY; NONTYPEABLE HAEMOPHILUS INFLUENZAE; PRIMARY CULTURE; PRIORITY JOURNAL; PROMOTER REGION; PSEUDOMONAS AERUGINOSA; SEROTYPE; STIMULUS; TRANSCRIPTION INITIATION; VIRUS INFECTION; VIRUS REPLICATION; AGONISTS; BIOSYNTHESIS; BRONCHUS; DRUG EFFECTS; GENETICS; HAEMOPHILUS INFLUENZAE; HELA CELL LINE; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; RHINOVIRUS; RNA STABILITY; SEROTYPING; TIME FACTOR; VIROLOGY;

BRONCHI; CHEMOKINE CCL20; DACTINOMYCIN; EPITHELIAL CELLS; HAEMOPHILUS INFLUENZAE; HELA CELLS; HETEROCYCLIC COMPOUNDS, 3-RING; HUMANS; NF-KAPPA B; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN KINASE INHIBITORS; PYRIDINES; RHINOVIRUS; RNA STABILITY; RNA, MESSENGER; SEROTYPING; TIME FACTORS; TOLL-LIKE RECEPTORS; VIRUS REPLICATION;

EID: 85018426633     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00362.2016     Document Type: Article

References (35)

1. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 4: 499-511, 2004. doi:10.1038/nri1391.
2. Bain J, Plater L, Elliott M, Shpiro N, Hastie CJ, McLauchlan H, Klevernic I, Arthur JS, Alessi DR, Cohen P. The selectivity of protein kinase inhibitors: a further update. Biochem J 408: 297-315, 2007. doi:10.1042/BJ20070797.
3. Battaglia F, Delfino S, Merello E, Puppo M, Piva R, Varesio L, Bosco MC. Hypoxia transcriptionally induces macrophage-inflammatory protein-3α/CCL-20 in primary human mononuclear phagocytes through nuclear factor (NF)-kappaB. J Leukoc Biol 83: 648-662, 2008. doi:10.1189/jlb.0607349.
4. Celli BR, Barnes PJ. Exacerbations of chronic obstructive pulmonary disease. Eur Respir J 29: 1224-1238, 2007. doi:10.1183/09031936.00109906.
5. Churchill L, Chilton FH, Resau JH, Bascom R, Hubbard WC, Proud D. Cyclooxygenase metabolism of endogenous arachidonic acid by cultured human tracheal epithelial cells. Am Rev Respir Dis 140: 449-459, 1989. doi:10.1164/ajrccm/140.2.449.
6. Collison A, Hatchwell L, Verrills N, Wark PA, de Siqueira AP, Tooze M, Carpenter H, Don AS, Morris JC, Zimmermann N, Bartlett NW, Rothenberg ME, Johnston SL, Foster PS, Mattes J. The E3 ubiquitin ligase midline 1 promotes allergen and rhinovirus-induced asthma by inhibiting protein phosphatase 2A activity. Nat Med 19: 232-237, 2013. doi:10.1038/nm.3049.
7. Davies SP, Reddy H, Caivano M, Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351: 95-105, 2000. doi:10.1042/bj3510095.
8. Deng JC. Viral-bacterial interactions-therapeutic interventions. Influenza Other Respi Viruses 7: 24-35, 2013. doi:10.1111/irv.12174.
9. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, Trzaskos JM. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273: 18623-18632, 1998. doi:10.1074/jbc.273.29.18623.
10. Guarascio AJ, Ray SM, Finch CK, Self TH. The clinical and economic burden of chronic obstructive pulmonary disease in the USA. Clinicoecon Outcomes Res 5: 235-245, 2013.
11. Koetzler R, Zaheer RS, Newton R, Proud D. Nitric oxide inhibits IFN regulatory factor 1 and nuclear factor-kappaB pathways in rhinovirusinfected epithelial cells. J Allergy Clin Immunol 124: 551-557, 2009. doi:10.1016/j.jaci.2009.04.041.
12. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Bin Abdulhak A, Birbeck G, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M, Burney P, Carapetis J, Chen H, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahodwala N, De Leo D, Degenhardt L, Delossantos A, Denenberg J, Des Jarlais DC, Dharmaratne SD, Dorsey ER, Driscoll T, Duber H, Ebel B, Erwin PJ, Espindola P, Ezzati M, Feigin V, Flaxman AD, Forouzanfar MH, Fowkes FG, Franklin R, Fransen M, Freeman MK, Gabriel SE, Gakidou E, Gaspari F, Gillum RF, Gonzalez-Medina D, Halasa YA, Haring D, Harrison JE, Havmoeller R, Hay RJ, Hoen B, Hotez PJ, Hoy D, Jacobsen KH, James SL, Jasrasaria R, Jayaraman S, Johns N, Karthikeyan G, Kassebaum N, Keren A, Khoo JP, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Lipnick M, Lipshultz SE, Ohno SL, Mabweijano J, MacIntyre MF, Mallinger L, March L, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McDermott MM, McGrath J, Mensah GA, Merriman TR, Michaud C, Miller M, Miller TR, Mock C, Mocumbi AO, Mokdad AA, Moran A, Mulholland K, Nair MN, Naldi L, Narayan KM, Nasseri K, Norman P, O’Donnell M, Omer SB, Ortblad K, Osborne R, Ozgediz D, Pahari B, Pandian JD, Rivero AP, Padilla RP, Perez-Ruiz F, Perico N, Phillips D, Pierce K, Pope CA III, Porrini E, Pourmalek F, Raju M, Ranganathan D, Rehm JT, Rein DB, Remuzzi G, Rivara FP, Roberts T, De León FR, Rosenfeld LC, Rushton L, Sacco RL, Salomon JA, Sampson U, Sanman E, Schwebel DC, Segui-Gomez M, Shepard DS, Singh D, Singleton J, Sliwa K, Smith E, Steer A, Taylor JA, Thomas B, Tleyjeh IM, Towbin JA, Truelsen T, Undurraga EA, Venketasubramanian N, Vijayakumar L, Vos T, Wagner GR, Wang M, Wang W, Watt K, Weinstock MA, Weintraub R, Wilkinson JD, Woolf AD, Wulf S, Yeh PH, Yip P, Zabetian A, Zheng ZJ, Lopez AD, Murray CJ, AlMazroa MA, Memish ZA. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2095-2128, 2012. doi:10.1016/S0140-6736(12)61728-0.
13. Matsusaka T, Fujikawa K, Nishio Y, Mukaida N, Matsushima K, Kishimoto T, Akira S. Transcription factors NF-IL6 and NF-κ B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin8. Proc Natl Acad Sci USA 90: 10193-10197, 1993. doi:10.1073/pnas.90.21.10193.
14. McManus TE, Marley A-M, Baxter N, Christie SN, O’Neill HJ, Elborn JS, Coyle PV, Kidney JC. Respiratory viral infection in exacerbations of COPD. Respir Med 102: 1575-1580, 2008. doi:10.1016/j.rmed.2008.06.006.
15. Newton R, Holden NS, Catley MC, Oyelusi W, Leigh R, Proud D, Barnes PJ. Repression of inflammatory gene expression in human pulmonary epithelial cells by small-molecule IkappaB kinase inhibitors. J Pharmacol Exp Ther 321: 734-742, 2007. doi:10.1124/jpet.106.118125.
16. Papi A, Bellettato CM, Braccioni F, Romagnoli M, Casolari P, Caramori G, Fabbri LM, Johnston SL. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 173: 1114-1121, 2006. doi:10.1164/rccm.200506-859OC.
17. Patel IS, Seemungal TA, Wilks M, Lloyd-Owen SJ, Donaldson GC, Wedzicha JA. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax 57: 759-764, 2002. doi:10.1136/thorax.57.9.759.
18. Pauwels RA, Buist AS, Calverley PMA, Jenkins CR, Hurd SS; GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 163: 1256-1276, 2001. doi:10.1164/ajrccm.163.5.2101039.
19. Proud D, Leigh R. Epithelial cells and airway diseases. Immunol Rev 242: 186-204, 2011. doi:10.1111/j.1600-065X.2011.01033.x.
20. Sanders SP, Siekierski ES, Porter JD, Richards SM, Proud D. Nitric oxide inhibits rhinovirus-induced cytokine production and viral replication in a human respiratory epithelial cell line. J Virol 72: 934-942, 1998.
21. Scapini P, Crepaldi L, Pinardi C, Calzetti F, Cassatella MA. CCL20/macrophage inflammatory protein-3α production in LPS-stimulated neutrophils is enhanced by the chemoattractant formyl-methionyl-leucylphenylalanine and IFN-γ through independent mechanisms. Eur J Immunol 32: 3515-3524, 2002. doi:10.1002/1521-4141(200212)32:12<3515:: AID-IMMU35153.0.CO;2-3.
22. Schutyser E, Struyf S, Van Damme J. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev 14: 409-426, 2003. doi:10.1016/S1359-6101(03)00049-2.
23. Seemungal T, Harper-Owen R, Bhowmik A, Moric I, Sanderson G, Message S, Maccallum P, Meade TW, Jeffries DJ, Johnston SL, Wedzicha JA. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164: 1618-1623, 2001. doi:10.1164/ajrccm.164.9.2105011.
24. Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 359: 2355-2365, 2008. doi:10.1056/NEJMra0800353.
25. Soler-Cataluña JJ, Martínez-García MA, Román Sánchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 60: 925-931, 2005. doi:10.1136/thx.2005.040527.
26. Starner TD, Barker CK, Jia HP, Kang Y, McCray PB Jr. CCL20 is an inducible product of human airway epithelia with innate immune properties. Am J Respir Cell Mol Biol 29: 627-633, 2003. doi:10.1165/rcmb.2002-0272OC.
27. Subauste MC, Jacoby DB, Richards SM, Proud D. Infection of a human respiratory epithelial cell line with rhinovirus. Induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J Clin Invest 96: 549-557, 1995. doi:10.1172/JCI118067.
28. van Ewijk BE, van der Zalm MM, Wolfs TF, van der Ent CK. Viral respiratory infections in cystic fibrosis. J Cyst Fibros 4, Suppl 2: 31-36, 2005. doi:10.1016/j.jcf.2005.05.011.
29. Wang X, Lau C, Wiehler S, Pow A, Mazzulli T, Gutierrez C, Proud D, Chow C-W. Syk is downstream of intercellular adhesion molecule-1 and mediates human rhinovirus activation of p38 MAPK in airway epithelial cells. J Immunol 177: 6859-6870, 2006. doi:10.4049/jimmunol.177.10.6859.
30. Wark PA, Tooze M, Powell H, Parsons K. Viral and bacterial infection in acute asthma and chronic obstructive pulmonary disease increases the risk of readmission. Respirology 18: 996-1002, 2013. doi:10.1111/resp.12099.
31. Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. Lancet 370: 786-796, 2007. doi:10.1016/S0140-6736(07)61382-8.
32. Wiehler S, Proud D. Interleukin-17A modulates human airway epithelial responses to human rhinovirus infection. Am J Physiol Lung Cell Mol Physiol 293: L505-L515, 2007. doi:10.1152/ajplung.00066.2007.
33. Wilkinson TM, Hurst JR, Perera WR, Wilks M, Donaldson GC, Wedzicha JA. Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD. Chest 129: 317-324, 2006. doi:10.1378/chest.129.2.317.
34. Wilkinson TM, Patel IS, Wilks M, Donaldson GC, Wedzicha JA. Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167: 1090-1095, 2003. doi:10.1164/rccm.200210-1179OC.
35. Zaheer RS, Koetzler R, Holden NS, Wiehler S, Proud D. Selective transcriptional down-regulation of human rhinovirus-induced production of CXCL10 from airway epithelial cells via the MEK1 pathway. J Immunol 182: 4854-4864, 2009. doi:10.4049/jimmunol.0802401.